Literature DB >> 29508284

NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications.

Shalini Singh1, Sushmita Jha2.   

Abstract

Nucleotide binding domain, leucine-rich repeat containing proteins (NLRs) are a family of pattern recognition receptors involved in major innate immune defense mechanisms. NLRs play a key role in several cancers, autoimmune, and inflammation-associated diseases. Association of NLRP3 has been widely investigated in neurodegenerative diseases, chronic alcoholism, depression, traumatic brain injury, and pathogenic infections. Several research studies have shown possible involvement of various other inflammasome-forming and non-inflammasome-forming NLRs in the brain; however, their mechanisms of action are yet to be defined clearly. Our review provides a comprehensive overview of the expression of NLRs in human brain and their critical association with inflammation and neurodegenerative diseases. The review also summarizes promising NLR-targeted therapeutics and their prospects for brain pathologies.

Entities:  

Keywords:  Inflammasome; Innate immunity; Microglia; NLRs; Neurodegenerative diseases; Neuroinflammation

Mesh:

Substances:

Year:  2018        PMID: 29508284     DOI: 10.1007/s12035-018-0957-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  257 in total

Review 1.  Effects of stress on the immune system.

Authors:  D N Khansari; A J Murgo; R E Faith
Journal:  Immunol Today       Date:  1990-05

2.  NLRP2 is highly expressed in a mouse model of ischemic stroke.

Authors:  Xia Sun; Xiao Song; Li Zhang; Jian Sun; Xinbing Wei; Liya Meng; Jie An
Journal:  Biochem Biophys Res Commun       Date:  2016-09-29       Impact factor: 3.575

3.  Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.

Authors:  David Yang-Wei Fann; Yun-An Lim; Yi-Lin Cheng; Ker-Zhing Lok; Prasad Chunduri; Sang-Ha Baik; Grant R Drummond; S Thameem Dheen; Christopher G Sobey; Dong-Gyu Jo; Christopher Li-Hsian Chen; Thiruma V Arumugam
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

Review 4.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

5.  Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes.

Authors:  K Suk; S Yeou Kim; H Kim
Journal:  Immunol Lett       Date:  2001-06-01       Impact factor: 3.685

6.  The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy.

Authors:  Yu Lei; Haitao Wen; Jenny P Y Ting
Journal:  Autophagy       Date:  2013-01-15       Impact factor: 16.016

7.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

8.  Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.

Authors:  Hiroe Honda; Yoshinori Nagai; Takayuki Matsunaga; Naoki Okamoto; Yasuharu Watanabe; Koichi Tsuneyama; Hiroaki Hayashi; Isao Fujii; Masashi Ikutani; Yoshikatsu Hirai; Atsushi Muraguchi; Kiyoshi Takatsu
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

9.  Prion pathogenesis in the absence of NLRP3/ASC inflammasomes.

Authors:  Mario Nuvolone; Silvia Sorce; Petra Schwarz; Adriano Aguzzi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

10.  Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury.

Authors:  Thomas Brickler; Kisha Gresham; Armand Meza; Sheryl Coutermarsh-Ott; Tere M Williams; Daniel E Rothschild; Irving C Allen; Michelle H Theus
Journal:  Mediators Inflamm       Date:  2016-04-20       Impact factor: 4.711

View more
  3 in total

Review 1.  Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases.

Authors:  Bo-Zong Shao; Qi Cao; Chong Liu
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

Review 2.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

3.  NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression.

Authors:  Shanshan Li; Yiming Sun; Mengmeng Song; Yuting Song; Yinquan Fang; Qingyu Zhang; Xueting Li; Nanshan Song; Jianhua Ding; Ming Lu; Gang Hu
Journal:  JCI Insight       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.